Production (Stage)
VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -757.00K | -917.30K | -1.04M | -882.20K | -909.30K |
| Total Depreciation and Amortization | 11.00K | 11.40K | 11.50K | 12.00K | 12.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.40K | 424.70K | 84.50K | 45.40K | 83.70K |
| Change in Net Operating Assets | 219.60K | -25.50K | 136.70K | 177.20K | 84.40K |
| Cash from Operations | -514.90K | -506.70K | -804.60K | -647.70K | -729.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | 300.00K | 1.13M | -- | -- |
| Total Debt Repaid | -29.40K | -29.40K | -29.40K | -69.40K | -29.40K |
| Issuance of Common Stock | 554.90K | 264.80K | 0.00 | 37.60K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -68.30K | -46.90K | -59.40K | -- | -- |
| Cash from Financing | 505.20K | 358.20K | 757.30K | -23.60K | -21.60K |
| Foreign Exchange rate Adjustments | -26.10K | 5.70K | -3.40K | -10.60K | 8.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.80K | -142.90K | -50.70K | -681.90K | -741.70K |